From Hyper- to Hypoinsulinemia and Diabetes: Effect of KCNH6 on Insulin Secretion

Jin-Kui Yang1, Jing Lu1, Sha-Sha Yuan1

  • 1Beijing Key Laboratory of Diabetes Research and Care, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.

Cell Reports
|December 28, 2018
PubMed

Insights

A novel non-ATP-sensitive potassium channel, KCNH6, is crucial for insulin secretion and glucose balance. Its dysfunction leads to initial hyperinsulinemia followed by beta cell failure and diabetes.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Insulin secretion is primarily regulated by ATP-sensitive potassium (KATP) channels in pancreatic islet beta cells.
  • The function of non-ATP-sensitive potassium (non-KATP) channels, such as KCNH6, in insulin secretion remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role of the non-KATP K+ channel KCNH6 in insulin secretion and glucose homeostasis.
  • To elucidate the molecular mechanisms underlying KCNH6 dysfunction in diabetes.

Main Methods:

  • Human genetic analysis of a four-generation pedigree with a KCNH6 mutation.
  • Generation and analysis of Kcnh6 knockout (KO) and knockin (KI) mouse models.
  • Assessment of islet function, intracellular calcium levels, endoplasmic reticulum (ER) stress, and apoptosis in mouse models.

Main Results:

  • A heterozygous KCNH6 p.P235L mutation was linked to diabetes in humans.
  • Kcnh6 KO/KI mice exhibited a progression from hypoglycemia with hyperinsulinemia to hyperglycemia with insulin deficiency.
  • Early-stage KO islets showed increased intracellular calcium and insulin secretion, while adult KO islets displayed ER stress, apoptosis, reduced beta cell mass, and impaired insulin secretion.

Conclusions:

  • KCNH6 is a critical regulator of insulin secretion and glucose homeostasis in both humans and mice.
  • KCNH6 dysfunction initially causes insulin hypersecretion, leading to beta cell exhaustion, ER stress, apoptosis, and ultimately, diabetes.

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
2.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.9K
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.2K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
731
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.3K